Skip to main content

Table 1 Baseline characteristics and clinical outcome of hemorrhagic fever renal syndrome patients with and without acute pancreatitis

From: Acute pancreatitis associated with hemorrhagic fever with renal syndrome: a cohort study of 346 patients

 

Case (n = 29)

Control (n = 317)

P value

Age, year (mean ± SD)

44.4 ± 16.4

46.2 ± 17.3

0.63

Male sex

19 (65.5%)

236 (74.4%)

0.32

Smoker

11 (37.9%)

132 (41.6%)

0.02

Alcoholics

9 (31.0%)

40 (12.6%)

0.03

Comorbidities

 No comorbidities

14 (48.3%)

185 (58.4%)

0.33

 Cardiovascular disease

6 (20.7%)

39 (12.3%)

0.24

 Diabetes

2 (6.9%)

23 (7.3%)

> 0.99

 Chronic liver disease

2 (6.9%)

22 (6.9%)

> 0.99

 Biliary tract disease

3 (10.3%)

8 (2.5%)

0.06

 Chronic respiratory disease

2 (6.9%)

9 (2.8%)

0.23

 Pregnancy

1 (3.5%)

4 (1.3%)

0.36

 Chronic renal disease

0 (0)

4 (1.3%)

> 0.99

 Solid tumor

0 (0)

2 (0.6%)

> 0.99

 Others

2 (6.9%)

37 (11.7%)

0.76

Days from symptom onset to hospitalization, d (mean ± SD)

4.6 ± 2.6

6.4 ± 5.4

0.02

Presenting symptoms

 Fever

24 (82.8%)

278 (87.7%)

0.39

 Back/Flank pain

14 (48.3%)

199 (62.8%)

0.16

 Gastrointestinal symptoms

20 (69.0%)

98 (30.9%)

< 0.01

  Nausea/vomiting

2 (6.9%)

11 (3.5%)

0.30

  Abdominal pain

8 (27.6%)

37 (11.7%)

0.04

  Diarrhea

7 (24.1%)

41 (12.9%)

0.09

  Abdominal distention

3 (10.3%)

9 (2.8%)

0.06

 Shock

5 (17.2%)

28 (8.8%)

0.18

Treatment

 Antibiotic therapy (mean ± SD)

1.7 ± 1.2

0.7 ± 0.8

0.01

 ICU admission

13 (44.8%)

12 (3.8%)

< 0.01

 ICU-free days at day 28, d (mean ± SD)

19.1 ± 10.2

27.1 ± 4.8

< 0.01

 RRT

17 (58.6%)

69 (21.8%)

< 0.01

 RRT-free days at day 28, d (mean ± SD)

18.6 ± 11.4

25.2 ± 6.5

< 0.01

 Mechanical ventilation

9 (31.0%)

8 (2.5%)

< 0.01

 Ventilator-free days at day 28, d (mean ± SD)

21.3 ± 11.5

27.4 ± 4.1

< 0.01

Clinical outcome

 90-day mortality

7 (24.1%)

7 (2.2%)

< 0.01

 Hospital-free days at day 28, d (mean ± SD)

8.6 ± 8.4

16.4 ± 6.6

0.005

  1. ICU Intensive care unit, RRT Renal replacement therapy
  2. Data are presented as the number (percentage) of patients unless indicated otherwise